Poor prognosis acute myelogenous leukemia 2 — biological and molecular biological characteristics and treatment outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Poor prognosis acute myelogenous leukemia 2 — biological and molecular biological characteristics and treatment outcome

Published:2000-09 Issue:9 Volume:24 Page:777-789
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Li Biarou,Yang Jie,Tao Ming,Nayini Jaya,Horvath Erzsebet,Chopra Harpareet,Meyer PeterM,Venugopal Paramesaran,Preisler Harvey D

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference46 articles.

1. High dose cytosine arabinoside as the initial treatment of poor risk patients with acute nonlymphocytic leukemia: A Leukemia Intergroup Study;Preisler;J. Clin. Oncol.,1987

2. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemia syndrome;Gajewski;J. Clin. Oncol.,1989

3. The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukemia: response to treatment and treatment failure;Preisler;Br. J. Haematol.,1991

4. MDR1 transcript levels as an indication of resistant disease in acute nonlymphocytic leukemia;Sato;Br. J. Haematol.,1990

5. Regrowth resistance in leukemia and lymphoma: The need for a new system to classify treatment failure and for new approaches to treatment;Preisler;Leuk. Res.,1994

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53-Induced Apoptosis and Inhibitors of p53;Current Medicinal Chemistry;2009-07-01

2. Poor prognosis acute myelogenous leukemia: 3—biological and molecular biological changes during remission induction therapy;Leukemia Research;2001-09

3. Current Awareness;Hematological Oncology;2001

4. Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine);Leukemia Research;2000-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3